BACKGROUND: We have previously demonstrated that MHC class I disparate hearts transplanted into miniature swine treated with a short course of cyclosporine developed florid cardiac allograft vasculopathy (CAV) and were rejected within 55 days. However, when a donor-specific kidney is cotransplanted with the heart allograft, recipients become tolerant to donor antigen and accept both allografts long-term without the development of CAV. In the present study, we have investigated the role of the host thymus in the induction of tolerance and prevention of CAV in heart/kidney recipients. METHODS: Total thymectomies were performed in six animals (postoperative day [POD]-21), which on day 0 received either an isolated MHC class I disparate heart allograft (n=3) or combined class I disparate heart and kidney allografts (n=3), followed in both cases by a 12-day course of cyclosporine (POD 0-11). Graft survival and the development of CAV in these thymectomized recipients were compared to the same parameters in non-thymectomized, cyclosporine-treated recipients bearing either class I disparate heart allografts (n=5) or heart and kidney allografts (n=4). RESULTS: In the group of animals bearing isolated class I disparate heart allografts, the thymectomized recipients rejected their allografts earlier (POD 8, 22, 27) than the non-thymectomized recipients (POD 33,35,45,47,55). The donor hearts in both the thymectomized and non-thymectomized animals developed florid CAV. In the group of animals bearing combined class I disparate heart and kidney allografts, the nonthymectomized recipients accepted both donor organs long term with no evidence of CAV. In contrast, none of the thymectomized heart/kidney recipients survived >100 days, and they all developed the intimal proliferation of CAV. CONCLUSION: Thymic-dependent mechanisms are necessary for the induction of acquired tolerance and prevention of CAV in porcine heart/kidney recipients.
BACKGROUND: We have previously demonstrated that MHC class I disparate hearts transplanted into miniature swine treated with a short course of cyclosporine developed florid cardiac allograft vasculopathy (CAV) and were rejected within 55 days. However, when a donor-specific kidney is cotransplanted with the heart allograft, recipients become tolerant to donor antigen and accept both allografts long-term without the development of CAV. In the present study, we have investigated the role of the host thymus in the induction of tolerance and prevention of CAV in heart/kidney recipients. METHODS: Total thymectomies were performed in six animals (postoperative day [POD]-21), which on day 0 received either an isolated MHC class I disparate heart allograft (n=3) or combined class I disparate heart and kidney allografts (n=3), followed in both cases by a 12-day course of cyclosporine (POD 0-11). Graft survival and the development of CAV in these thymectomized recipients were compared to the same parameters in non-thymectomized, cyclosporine-treated recipients bearing either class I disparate heart allografts (n=5) or heart and kidney allografts (n=4). RESULTS: In the group of animals bearing isolated class I disparate heart allografts, the thymectomized recipients rejected their allografts earlier (POD 8, 22, 27) than the non-thymectomized recipients (POD 33,35,45,47,55). The donor hearts in both the thymectomized and non-thymectomized animals developed florid CAV. In the group of animals bearing combined class I disparate heart and kidney allografts, the nonthymectomized recipients accepted both donor organs long term with no evidence of CAV. In contrast, none of the thymectomized heart/kidney recipients survived >100 days, and they all developed the intimal proliferation of CAV. CONCLUSION: Thymic-dependent mechanisms are necessary for the induction of acquired tolerance and prevention of CAV in porcine heart/kidney recipients.
Authors: H Sahara; M J Weiss; C Y Ng; S L Houser; A C Pujara; J K Sayre; J C Wain; D H Sachs; J C Madsen; J S Allan Journal: Transplant Proc Date: 2006-12 Impact factor: 1.066
Authors: M L Madariaga; S G Michel; G M La Muraglia; M Sekijima; V Villani; D A Leonard; H J Powell; J M Kurtz; E A Farkash; R B Colvin; J S Allan; C L Cetrulo; C A Huang; D H Sachs; K Yamada; J C Madsen Journal: Am J Transplant Date: 2015-03-30 Impact factor: 8.086
Authors: M L L Madariaga; P J Spencer; S G Michel; G M La Muraglia; M J O'Neil; E C Mannon; C Leblang; I A Rosales; R B Colvin; D H Sachs; J S Allan; J C Madsen Journal: Am J Transplant Date: 2015-10-15 Impact factor: 8.086
Authors: Makoto Tonsho; Sebastian Michel; Zain Ahmed; Alessandro Alessandrini; Joren C Madsen Journal: Cold Spring Harb Perspect Med Date: 2014-05-01 Impact factor: 6.915
Authors: M Tasaki; V Villani; A Shimizu; M Sekijima; R Yamada; I M Hanekamp; J S Hanekamp; T A Cormack; S G Moran; A Kawai; D H Sachs; K Yamada Journal: Am J Transplant Date: 2016-06-13 Impact factor: 8.086
Authors: M L Madariaga; S G Michel; M Tasaki; V Villani; G M La Muraglia; S Sihag; J Gottschall; E A Farkash; A Shimizu; J S Allan; D H Sachs; K Yamada; J C Madsen Journal: Am J Transplant Date: 2013-08-22 Impact factor: 8.086
Authors: M Okumi; J R Scalea; B C Gillon; M Tasaki; V Villani; T Cormack; A Hirakata; A Shimizu; D H Sachs; K Yamada Journal: Am J Transplant Date: 2013-03-06 Impact factor: 8.086